Suraj Kalia
Stock Analyst at Oppenheimer
(3.39)
# 882
Out of 4,829 analysts
78
Total ratings
43.28%
Success rate
5.04%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Outperform | $125 → $130 | $111.50 | +16.59% | 10 | May 9, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $31.00 | +45.16% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $6.88 | +234.30% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $137.70 | -12.85% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $28.91 | +10.69% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $80.26 | +15.87% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $133.24 | -2.43% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $5.02 | +99.20% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $73.68 | +22.15% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $6.21 | +109.34% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $118.44 | +13.98% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $245.04 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $9.54 | +214.47% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.20 | +4,999.44% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $69.87 | +38.83% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $23.29 | +20.22% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.23 | +101.79% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.19 | +1,244.54% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $536.51 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.43 | +27,060.49% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $151.25 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.24 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $30.90 | +223.62% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $84.67 | - | 5 | Sep 12, 2018 |
TransMedics Group
May 9, 2025
Maintains: Outperform
Price Target: $125 → $130
Current: $111.50
Upside: +16.59%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $31.00
Upside: +45.16%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $6.88
Upside: +234.30%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $137.70
Upside: -12.85%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $28.91
Upside: +10.69%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $80.26
Upside: +15.87%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $133.24
Upside: -2.43%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.02
Upside: +99.20%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $73.68
Upside: +22.15%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $6.21
Upside: +109.34%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $118.44
Upside: +13.98%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $245.04
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $9.54
Upside: +214.47%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.20
Upside: +4,999.44%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $69.87
Upside: +38.83%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $23.29
Upside: +20.22%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.23
Upside: +101.79%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.19
Upside: +1,244.54%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $536.51
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.43
Upside: +27,060.49%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $151.25
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.24
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $30.90
Upside: +223.62%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $84.67
Upside: -